A case demonstrates hair regrowth in frontal fibrosing alopecia using combination therapy, suggesting early treatment's potential benefit.
Frontal fibrosing alopecia (FFA) is a primary lymphocytic cicatricial alopecia that commonly presents with progressive frontotemporal hairline recession and eyebrow loss. Effective treatment remains challenging. We describe a 36-year-old woman with active postpartum-onset FFA who demonstrated significant improvement following combination therapy, including dutasteride, tofacitinib, and intralesional triamcinolone acetonide. This case highlights the potential benefit of early multimodal therapy in promoting regrowth in FFA, a condition typically associated with irreversible follicular loss.
No takes yet. Share an insight, caveat, or question.
Kadasa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: